THCTENET HEALTHCARE CORP

NYSE tenethealth.com


$ 137.53 $ 0.63 (0.46 %)    

Tuesday, 18-Jun-2024 15:59:57 EDT
QQQ $ 485.28 $ 0.15 (0.03 %)
DIA $ 389.19 $ 0.56 (0.14 %)
SPY $ 548.51 $ 1.39 (0.25 %)
TLT $ 94.60 $ 0.86 (0.92 %)
GLD $ 215.51 $ 0.86 (0.4 %)
$ 137.51
$ 136.90
$ 0.00 x 0
$ 0.00 x 0
$ 135.76 - $ 138.10
$ 51.04 - $ 142.36
787,262
na
13.83B
$ 2.23
$ 5.28
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-30-2024 03-31-2024 10-Q
2 02-16-2024 12-31-2023 10-K
3 10-30-2023 09-30-2023 10-Q
4 07-31-2023 06-30-2023 10-Q
5 04-28-2023 03-31-2023 10-Q
6 02-21-2023 12-31-2022 10-K
7 10-28-2022 09-30-2022 10-Q
8 07-29-2022 06-30-2022 10-Q
9 04-29-2022 03-31-2022 10-Q
10 02-18-2022 12-31-2021 10-K
11 10-29-2021 09-30-2021 10-Q
12 07-30-2021 06-30-2021 10-Q
13 04-30-2021 03-31-2021 10-Q
14 02-19-2021 12-31-2020 10-K
15 10-30-2020 09-30-2020 10-Q
16 08-03-2020 06-30-2020 10-Q
17 05-04-2020 03-31-2020 10-Q
18 02-24-2020 12-31-2019 10-K
19 11-04-2019 09-30-2019 10-Q
20 08-05-2019 06-30-2019 10-Q
21 04-29-2019 03-31-2019 10-Q
22 02-25-2019 12-31-2018 10-K
23 11-05-2018 09-30-2018 10-Q
24 08-06-2018 06-30-2018 10-Q
25 04-30-2018 03-31-2018 10-Q
26 02-26-2018 12-31-2017 10-K
27 11-07-2017 09-30-2017 10-Q
28 08-07-2017 06-30-2017 10-Q
29 05-01-2017 03-31-2017 10-Q
30 02-27-2017 12-31-2016 10-K
31 10-31-2016 09-30-2016 10-Q
32 08-01-2016 06-30-2016 10-Q
33 05-02-2016 03-31-2016 10-Q
34 02-22-2016 12-31-2015 10-K
35 11-02-2015 09-30-2015 10-Q
36 08-03-2015 06-30-2015 10-Q
37 05-04-2015 03-31-2015 10-Q
38 02-23-2015 12-31-2014 10-K
39 11-03-2014 09-30-2014 10-Q
40 08-04-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 jp-morgan-maintains-overweight-on-tenet-healthcare-raises-price-target-to-140

JP Morgan analyst Lisa Gill maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $107 to...

 deutsche-bank-maintains-buy-on-tenet-healthcare-raises-price-target-to-150

Deutsche Bank analyst Pito Chickering maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $126...

 baird-initiates-coverage-on-tenet-healthcare-with-outperform-rating-announces-price-target-of-153

Baird analyst Michael Ha initiates coverage on Tenet Healthcare (NYSE:THC) with a Outperform rating and announces Price Targ...

 which-large-cap-stocks-are-winning-this-earnings-season-15-stocks-to-watch-april-28-may-4-2024

Last week's top performers included Carvana, Pinterest, Moderna and JD.Com.

 barclays-maintains-overweight-on-tenet-healthcare-raises-price-target-to-147

Barclays analyst Andrew Mok maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $113 to...

 rbc-capital-maintains-outperform-on-tenet-healthcare-raises-price-target-to-136

RBC Capital analyst Ben Hendrix maintains Tenet Healthcare (NYSE:THC) with a Outperform and raises the price target from $10...

 ubs-maintains-buy-on-tenet-healthcare-raises-price-target-to-150

UBS analyst A.J. Rice maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $137 to $150.

 mizuho-reiterates-buy-on-tenet-healthcare-raises-price-target-to-130

Mizuho analyst Ann Hynes reiterates Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $118 to $130.

 truist-securities-reiterates-buy-on-tenet-healthcare-raises-price-target-to-130

Truist Securities analyst David Macdonald reiterates Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from...

 stephens--co-maintains-equal-weight-on-tenet-healthcare-raises-price-target-to-122

Stephens & Co. analyst Scott Fidel maintains Tenet Healthcare (NYSE:THC) with a Equal-Weight and raises the price target...

 why-is-hospital-chain-operator-tenet-healthcare-stock-soaring-on-tuesday

Discover Tenet Healthcare's robust first-quarter performance, boasting $5.37 billion in sales, a 7% Y/Y increase. With stro...